Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.

Joseph LewisOmer IqbalWalter JeskeDebra Moorman Hoppensteadt Fakiha Siddiqui Jawed Fareed

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

Andexanet partially neutralized UFH and LMWH with variability between assays, necessitating investigation into assay-dependent differences.

Keyphrases

venous thromboembolism
high throughput
replacement therapy
growth factor
single cell